We are a data-driven asset manager specializing in private financing solutions for the cannabis sector and related businesses in psychedelics and regenerative medicine. We leverage our first-mover advantage in these industries, where businesses can be complex, markets are inefficient, and risk is often mispriced.
We do this by mastering and effectively utilizing our data. Our proprietary datasets enhance our portfolio companies’ performance and drive our investment decisions.
Equipped with real-time market data, a deep network, and a stellar reputation, we execute exclusive deals with conviction.
